VALENCIA, Calif., Jan. 31 /PRNewswire-FirstCall/ -- MannKind Corporation will release its 2006 fourth quarter financial results on Friday, February 2, 2007 at 7:00 a.m. EST.
Management of the Company will host a conference call to discuss the fourth quarter financial results, clinical progress and other Company developments at 9:00 a.m. EST on Friday, February 2, 2007. Presenting from the Company will be its Chairman and Chief Executive Officer, Alfred Mann; Corporate Vice President and Chief Scientific Officer, Peter Richardson; and Corporate Vice President and Chief Financial Officer, Dick Anderson.
To participate in the live call by telephone, please dial (888) 566-5775 or (210) 839-8503. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at www.mannkindcorp.com.
A telephone replay of the call will be available for 48 hours by dialing (866) 443-4144 or (203) 369-1112 and entering conference number 2363265. A replay will be available on MannKind's website for fourteen days.
About MannKind Corporation
MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.
MannKind CorporationCONTACT: Dick Anderson, Chief Financial Officer of MannKind Corporation,+1-661-775-5302, danderson@mannkindcorp.com; or Investor Relations, JulieHuang of Financial Dynamics, +1-212-850-5628, mnkd@fd.com, for MannKindCorporation
Web site: http://www.mannkindcorp.com/
